Overview
Tom Nicholson is an investor at PeakBridge [1][2]. Nicholson is also founder of The Transition Co., a position held since April 2025 [3]. Previously, Nicholson served as Chief of Staff at The Supplant Company from March 2019 to February 2025 [4]. Earlier roles include co-founder of Health Horizons from August 2018 to July 2019 [5], consultant at PRECISIONadvisors from October 2017 to August 2018 [6], and business development intern at Congenica from April to June 2017 [7]. Nicholson holds an MPhil in Bioscience Enterprise from the University of Cambridge [8], an MSc in Biotechnology from Rhodes University [9], and a BSc (Honours) in Biochemistry from Rhodes University [10].
Career history
- InvestorNov 2025 to presentPeakBridge
- FounderApr 2025 to presentThe Transition Co.
- Chief Of StaffMar 2019 to Feb 2025The Supplant Company
- Co-FounderAug 2018 to Jul 2019Health Horizons
- ConsultantOct 2017 to Aug 2018PRECISIONadvisors
- Business Development InternApr 2017 to Jun 2017Congenica
Education
MPhil, Bioscience EnterpriseUniversity of Cambridge
- MSc, BiotechnologyRhodes University
- BSc (Honours), BiochemistryRhodes University
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.